-
Letter to the editor on Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASL
Author: Zheng, Sheng
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e170-e171. DOI: 10.3350/cmh.2025.0656
-
Letter to the editor on Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosi
Author: Zheng, Bo; Wang, Lizhou
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e141-e143. DOI: 10.3350/cmh.2025.0521
-
Reply to correspondence on Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation stud
Author: Yao, Xingyu
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e267-e268. DOI: 10.3350/cmh.2025.0892
-
Letter to the editor on Glucagon-like peptide 1 receptoragonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation stud
Author: Yao, Xingyu
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e165-e166. DOI: 10.3350/cmh.2025.0620
-
Metabolic dysfunction-associated steatotic liver disease: On track to become the dominant etiology of hepatocellular carcinoma: Reply to correspondence on Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidatio
Author: Xu, Jian; Zhang, Wei; Wu, Guo; Li, Jingdong
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e257-e261. DOI: 10.3350/cmh.2025.0853
-
Critical flaws in the molecular classification of HCC based on metabolic zonation: Letter to the editor on Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathwa
Author: Xie, Yongzhi; Zhu, Xiangyu; Liang, Qi
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e144-e145. DOI: 10.3350/cmh.2025.0610
-
Sex-specific trends and demographic vs. epidemiologic drivers of alcohol-related cirrhosis in United States, 2021-2040: Letter to the editor on Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United State
Author: Wang, Kui; Zeng, Yunqing
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e155-e157. DOI: 10.3350/cmh.2025.0790
-
Hepatitis B in Africa: Progress toward World Health Organization 2030 targets, persistent disparities, and COVID-19 setback
Author: Wang, Kui; Zhou, Ruchen
Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2026; Vol. 32, Issue 2, pp. e211-e215. DOI: 10.3350/cmh.2026.0151
